Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
We are all waiting for this announcement ..
Volumes increasing always have a special meaning ...
This is just the beginning
Of a long race towards north
goooooooooo!!!! 0,002 today
Look in the book
MM 0.001 CAR CAN NOW GO TO NORTH
MM AUTO blocking the movement upwards.
In italy diaaf love.
gooooooooooooooo!!!!!
http://www.rallymonkey.com/oldvideo.php
7x10
gooooooooooooooooooo
Harr hello,,,
It is rather more that do not follow the title
Please me you can upgrade if there are
The news ..
Thanks
We need a confirmation news ..
With related income ...
We need new investors
0.001 for breaking only then so can
Off ...
It's coming
Flies diaaf
a/s o/s????
thanks
Bingo,,,, gentlemen google.
If you read the good news google does not say much ...
Not even talking new contracts, money which will come
In the vaults of diaaf ...
We need a new story with written how much money
Invest in the future ...
It is only my opinion.
There is an air of expectation in the book ..
Is firm, volumes low
Large investors ready?
a/s o/s ???
thanks
I am with you expect great news ....
I want to see him fly a few cents.
a/s o/s ?
thanks
Now it's too late for the news ...
Monday '
today?
relax
auto= diluitor
You noticed the game is in hand
MM is a AUTO
Now what is your forecast ..
Move as' the thiol green ..?
I saw the buy confirmed
I think it has no meaning, we
Need PR
error
65Mx0,0002=$13,000
56M sold shares 0.0002
Equivalent $ 13.000
I do not think it is a good sign ..
Expect today
Excellent product ...
The company is solid
Too silence on the part of
People are tired of waiting for someone sold ...
Maybe tomorrow leaves a news ...
I think we are all sales
All news can also google
This week ...
Now that fall volumes great news.
All this when ???....
Short a month two months ....
Is not a good sign this fall in volumes.
Mistake?
Dilution over?
Are pessimists do not believe that it can
Off the title?
I regret that I see dead volume.
Bag,
I am not capable is the first thread
I open forum, I would be happy to have you at my side
You alone you can add?
With pleasure,
You can add alone or should I do it?
I do not see auto MM (diluter)
Excellent signal ..
Corgenix Reports Second Quarter Fiscal 2008 Financial Results
Tuesday February 12, 9:15 am ET
Revenues for the Quarter Increase More Than 42% over Prior Year
DENVER--(BUSINESS WIRE)--Corgenix Medical Corporation (OTCBB: CONX - News), a worldwide developer and marketer of diagnostic test kits, today filed its 2nd quarter Form 10-QSB and reported financial results. The report disclosed that the company’s sales and operating results have advanced during the quarter and six months ended December 31, 2007, and further confirmed that the initiatives the company put in place several months earlier are proving very effective. Some of the results highlighted by the report are as follows:
Revenues for the quarter increased $714,227 or 42.4% over the prior year’s comparable quarter.
Total operating expenses decreased $326,074 or 22.5% vs. the prior year’s comparable quarter.
Operating income for the quarter was $224,224 vs. an operating loss of $435,039 in the prior year’s comparable quarter.
Net loss was dramatically reduced from $908,121 in the prior year’s comparable quarter to $60,310 in the current quarter.
“The initiatives which we implemented beginning in the final quarter of fiscal 2007 to increase sales and decrease operating expenses are definitely showing positive results,” said Douglass Simpson, President and CEO of Corgenix. “While we still have more work to do, these initiatives have materially reduced our operating expenses, improved our customer and sales experience and laid the groundwork to accelerate future revenue growth. Our Company is growing nicely and is very vibrant.”
The Company noted that the financial performance for the quarter was strong, with notable growth in core product revenue and substantially reduced net negative cash flow. The Company expects that Fiscal Year 2008 will be another record year for revenues.
“We are continuing to build a solid foundation for AspirinWorks®. Even though sales are not yet material, they are right on budget and should begin to pay off later in the current fiscal year, and especially in the years to come,” noted Luis Lopez, M.D., Corgenix Chairman and Chief Medical Officer. “Our AspirinWorks® and AtherOx® products are currently in over 34 clinical studies worldwide and we expect to see exciting news as these studies are completed and move to publication.”
Second Quarter 2008 Conference Call Details
Corgenix invites all those interested in hearing management's discussion of second quarter results to join a shareholders conference call on Tuesday, February 12, 2008, at 4:00 PM EST (2:00 PM MST). Interested parties can join the call by dialing 800-895-0198. International participants may access the call by dialing 785-424-1053. The conference code is “CORGENIX.” A replay will be available for 30 days following the call by dialing 800-727-6189 for domestic participants and 402-220-2671 for international participants.
About Corgenix Medical Corporation
Corgenix is a leader in the development and manufacturing of specialized diagnostic kits for immunology disorders, vascular diseases and bone and joint disorders. Corgenix diagnostic products are commercialized for use in clinical laboratories throughout the world. The company currently sells over 50 diagnostic products through a global distribution network and has significant experience advancing products through the FDA process. More information is available at www.corgenix.com.
Statements in this press release that are not strictly historical facts are “forward-looking” statements (identified by the words “believe,” “estimate,” “project,” “expect” or similar expressions) within the meaning of the Private Securities Litigation Reform Act of 1995. These statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, continued acceptance of the Company’s products and services in the marketplace, competitive factors, changes in the regulatory environment, and other risks detailed in the Company’s periodic report filings with the Securities and Exchange Commission. The statements in this press release are made as of today, based upon information currently known to management, and the company does not undertake any obligation to publicly update or revise any forward-looking statements.
SUMMARY OF FINANCIAL HIGHLIGHTS
($000 of U.S. dollars except shares outstanding and per share amounts)
CORGENIX MEDICAL CORPORATION AND SUBSIDIARIES
OPERATIONAL DATA
Three Months Ended
Six Months Ended
December
a/s o/s ?
thanks
Yet few days dilution,
And then we will be repaid.
Long